NDC product
Buprenorphine and Naloxone
NDC 0093-5721 · Teva Pharmaceuticals USA, Inc.
Key facts
| Product NDC | 0093-5721 |
|---|---|
| Proprietary name | Buprenorphine and Naloxone |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Marketing category | ANDA |
| Application number | ANDA091149 |
| Marketing start | Dec 10, 2014 |
| Marketing end | Oct 31, 2018 |
| Listing certified through | Oct 31, 2018 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: